Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS??? DEFICIT (Tables)

v3.22.4
STOCKHOLDERS’ DEFICIT (Tables)
6 Months Ended
Dec. 31, 2022
Equity [Abstract]  
SCHEDULE OF WARRANT ACTIVITY

The following table summarizes warrant activity for the six months ended December 31, 2022:

          Weighted  
    Number of     Average  
    Shares     Price Per Share  
Outstanding at June 30, 2022     105,420     $ 200.27  
Granted     3,305,000       0.01  
Exercised     (5,960 )     65.77  
Forfeited     (1,000 )     2,000.00  
Expired     -       -  
Outstanding at December 31, 2022     3,403,460 *   $ 5.51  
                 
Exercisable at December 31, 2022     3,379,711     $ 5.55  
Outstanding and Exercisable:                
                 
Weighted average remaining contractual term     2.58          
Aggregate intrinsic value
  $ -          

 

* The total warrants of 3,403,460 above consisted of the following:
SCHEDULE OF WARRANT OUTSTANDING AND EXERCISABLE

    Number of Warrants     Exercisable  
Series A warrants     9,986       9,986  
Series B warrants     23,750       23,750  
Series C warrants     63,749       40,000  
Warrants with no class designation     3,305,975       3,305,975  
Total     3,403,460       3,379,711  
SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY

A summary of the Company’s option activity during the six months ended December 31, 2022 is presented below:

 

          Weighted  
    Number of     Average Exercise  
  Shares     Price Per Share  
Outstanding at June 30, 2022     59     $ 4,533  
Granted     -       -  
Exercised     -       -  
Forfeited     -       -  
Expired     -       -  
Outstanding at December 31, 2022     59     $ 4,533  
                 
Exercisable at December 31, 2022     59     $ 4,533  
Outstanding and Exercisable:                
                 
Weighted average remaining contractual term     6.37          
Weighted average fair value of options granted during the period   $ -          
Aggregate intrinsic value   $ -